This was a multicentre , randomised , double-blind , placebo-controlled , three-way cross-over , incomplete block study to evaluate UMEC @ , @ , @ , and @ g administered once daily ( QD ) , and UMEC @ g and @ g administered twice daily ( BID ) , over @ days in patients with COPD .